全文获取类型
收费全文 | 2812篇 |
免费 | 217篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 112篇 |
妇产科学 | 35篇 |
基础医学 | 646篇 |
口腔科学 | 93篇 |
临床医学 | 393篇 |
内科学 | 587篇 |
皮肤病学 | 117篇 |
神经病学 | 87篇 |
特种医学 | 271篇 |
外科学 | 219篇 |
综合类 | 68篇 |
预防医学 | 123篇 |
眼科学 | 43篇 |
药学 | 175篇 |
中国医学 | 1篇 |
肿瘤学 | 76篇 |
出版年
2018年 | 34篇 |
2016年 | 32篇 |
2015年 | 46篇 |
2014年 | 42篇 |
2013年 | 94篇 |
2012年 | 46篇 |
2011年 | 46篇 |
2010年 | 61篇 |
2009年 | 43篇 |
2008年 | 44篇 |
2007年 | 83篇 |
2006年 | 66篇 |
2005年 | 49篇 |
2004年 | 50篇 |
2003年 | 55篇 |
2002年 | 45篇 |
2001年 | 54篇 |
2000年 | 47篇 |
1999年 | 48篇 |
1998年 | 90篇 |
1997年 | 106篇 |
1996年 | 109篇 |
1995年 | 78篇 |
1994年 | 88篇 |
1993年 | 94篇 |
1992年 | 68篇 |
1991年 | 56篇 |
1990年 | 55篇 |
1989年 | 75篇 |
1988年 | 67篇 |
1987年 | 63篇 |
1986年 | 58篇 |
1985年 | 49篇 |
1984年 | 55篇 |
1983年 | 33篇 |
1982年 | 32篇 |
1981年 | 42篇 |
1980年 | 55篇 |
1979年 | 36篇 |
1978年 | 37篇 |
1977年 | 42篇 |
1976年 | 49篇 |
1975年 | 40篇 |
1972年 | 30篇 |
1965年 | 51篇 |
1964年 | 50篇 |
1963年 | 48篇 |
1962年 | 41篇 |
1961年 | 40篇 |
1960年 | 66篇 |
排序方式: 共有3059条查询结果,搜索用时 15 毫秒
81.
Non-invasive detection of fecal protein kinase C betaII and zeta messenger RNA: putative biomarkers for colon cancer 总被引:2,自引:0,他引:2
Davidson LA; Aymond CM; Jiang YH; Turner ND; Lupton JR; Chapkin RS 《Carcinogenesis》1998,19(2):253-257
We have developed a non-invasive method utilizing feces, containing
sloughed colonocytes, as a sensitive technique for detecting diagnostic
colonic biomarkers. In this study, we used the rat colon carcinogenesis
model to determine if changes in fecal protein kinase C (PKC) expression
have predictive value in monitoring the neoplastic process. Weanling rats
were injected with saline or azoxymethane (AOM) and 36 weeks later fecal
samples and mucosa were collected, poly A+ RNA isolated, and quantitative
RT-PCR performed using primers to PKC betaII and zeta. Fecal PKC betaII and
zeta mRNA levels were altered by the presence of a tumor, with
tumor-bearing animals having a 3-fold higher (P < 0.05) PKC betaII
expression as compared with animals without tumors. In addition,
AOM-injection increased mucosal PKC betaII mRNA expression compared with
saline controls. No effect of tumor incidence on mucosal PKC betaII
expression was observed. In contrast, fecal PKC zeta expression was
2.5-fold lower (P < 0.05) in animals injected with azoxymethane versus
saline. Since tumor incidence exerts a reciprocal effect on fecal PKC
betaII and zeta mRNA expression, data were also expressed as the ratio
between PKC betaII and zeta. The isozyme ratio was strongly related to
tumor incidence, i.e. ratio for animals with tumors was 2.18 +/- 1.25,
animals without tumors was 0.50 +/- 0.16, P = 0.025. We demonstrate that
the expression of fecal PKC betaII and zeta may serve as a noninvasive
marker for development of colon tumors. A sensitive technique for the
detection of colon cancer is of importance since early diagnosis can
substantially reduce mortality.
相似文献
82.
Epilepsy surgery has emerged as an important option in the treatment of children with epilepsy that is refractory to antiepileptic drug management. The cornerstone of successful surgery is accurate localization of the brain region of seizure onset. Traditional techniques of seizure onset localization, e.g. surface electroencephalography (EEG) recording and magnetic resonance imaging (MRI), allow accurate localization in a significant number of patients. When the focus of seizure onset is not apparent from these non-invasive techniques, other methods of localization, e.g. intracranial EEG recording, may be needed before resection of the focus. Single-photon emission computed tomography (SPECT) is a nuclear medicine blood-flow technique that has been used to identify a region of epileptogenic brain associated with low blood flow in the resting state (interictal SPECT) or increased blood flow at the time of seizure activity (ictal SPECT). This report describes the validation and utility of a computer-assisted method of subtracting the interictal from the ictal SPECT scans and co-registering the difference image on the MRI. This method, called subtraction ictal SPECT co-registered on MRI (SISCOM), is used in guiding the location and the extent of intracranial electrode implantation, or in obviating the need for the implantation in some cases. 相似文献
83.
E García‐Molina J Lacunza F Ruiz‐Espejo M Sabater A García‐Alberola JR Gimeno F Caizares A García P Martínez M Valds I Tovar 《Clinical genetics》2013,83(6):530-538
We aim to study the SCN5A gene in a cohort of Brugada syndrome (BS) patients and evaluate the genotype–phenotype correlation. BS is caused by mutations in up to 10 different genes, SCN5A being the most frequently involved. Large genomic rearrangements in SCN5A have been associated with conduction disease, but its prevalence in BS is unknown. Seventy‐six non‐related patients with BS were studied. Clinical characteristics and family risk profile were recorded. Direct sequencing and multiplex ligation‐dependent probe amplification (MLPA) of the SCN5A gene for identification of mutations and larger rearrangements were performed, respectively. Eight patients (10.5%) had point mutations (R27H, E901K, G1743R (detected in three families), V728I, N1443S and E1152X). Patients with mutations had a trend toward a higher proportion of spontaneous type I Brugada electrocardiogram (ECG) (87.5% vs 52.9%, p = 0.06) and had evidence of familial disease (62.5%, vs 23.5%, p = 0.03). The symptoms and risk profile of the carriers were not different from wild‐type probands. There were non‐significant differences in the prevalence of type I ECG, syncope and history of arrhythmia in carriers of selected polymorphisms. None of the patients had any deletion/duplication in the SCN5A gene. In conclusion, 10.5% of our patients had mutations in the SCN5A gene. Patients with mutations seemed to have more spontaneous type I ECG, but no differences in syncope or arrhythmic events compared with patients without mutations. Larger studies are needed to evaluate the role of polymorphisms in the SCN5A in the expression of the phenotype and prognosis. Large rearrangements were not identified in the SCN5A gene using the MLPA technique. 相似文献
84.
85.
86.
A randomized controlled pilot study feasibility of a tablet‐based guided audio‐visual relaxation intervention for reducing stress and pain in adults with sickle cell disease
下载免费PDF全文
![点击此处可从《Journal of advanced nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
87.
88.
89.
90.
Srisuda Ngamkham Catherine Vincent Lorna Finnegan Janean E. Holden Zaijie Jim Wang Diana J. Wilkie 《Pain Management Nursing》2012,13(1):27-51
First published in 1975, the McGill Pain Questionnaire (MPQ) is an often-cited pain measure, but there have been no systematic reviews of the MPQ in cancer populations. Our objective was to evaluate the MPQ as a multidimensional measure of pain in people with cancer. A systematic search of research that used the MPQ in adults with cancer and published in English from 1975 to 2009 was conducted. Twenty-one articles retrieved through computerized searches and nine studies from manual searches met the criteria. Review of the 30 studies demonstrated that pain intensity (n = 29 studies) and pain quality (n = 27 studies) were measured more frequently than pain location, pattern, and behavior parameters. Measuring cancer pain using the MPQ provided insights about disease sites, magnitude of pain, and effectiveness of treatment and intervention. Additionally, the MPQ data informed speculations about pain mechanisms, emotional status, overall sensory pain experience, changes in pain over time, and alleviating and aggravating behaviors/factors. Findings supported the MPQ as an effective multidimensional measure with good stability, content, construct, and criterion validity and showed sensitivity to treatment or known-group effects. The MPQ is a valid, reliable, and sensitive multidimensional measure of cancer pain. Cancer pain is a subjective complex experience consisting of multiple dimensions, and measuring cancer pain with the MPQ may help clinicians to more fully understand whether those dimensions of cancer pain influence each other. As a result, clinicians can provide better and effective cancer pain management. 相似文献